EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential

Giovanni Sette(Istituto Superiore di Sanità), Adriana Eramo(Istituto Superiore di Sanità)
PLoS ONE
October 8, 2012
Cited by 39


Related Papers